Trial Site Detail

 

Drug:
MEDI-573
Trial:
A Dose-Escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Karmanos Cancer Institute

4100 John R     
Detroit , MI 48201
USA

 

Principal Investigator:
Pat LoRusso, DO
Contact:
Adam Bowditch 313-576-9371 bowditch@karmanos.org
Activation Status of this Site:
Closed
Notes about this Site:
Karmanos Cancer Institute Website:
https://app-oncoreprod1.karmanos.org/sip/SIPControlServlet

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.